Latest debt-to-equity ratio
Kiniksa Pharmaceuticals International Debt-to-equity ratio
Direct answer
Kiniksa Pharmaceuticals International's debt-to-equity ratio is 1.36%.
The verified market snapshot reports 1.36%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 20, 2026.
Get free Kiniksa Pharmaceuticals International email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 1.36%
Explore related company data
View Kiniksa Pharmaceuticals International's market capitalizationView Kiniksa Pharmaceuticals International's p/e ratioView Kiniksa Pharmaceuticals International's price-to-book ratioView Kiniksa Pharmaceuticals International's return on equityView Kiniksa Pharmaceuticals International's dividend yieldView Kiniksa Pharmaceuticals International's 52-week price rangeView Kiniksa Pharmaceuticals International's revenue growthView Kiniksa Pharmaceuticals International's profit marginView all Kiniksa Pharmaceuticals International key metricsReturn to Kiniksa Pharmaceuticals International profile